Investor focus is likely to be on the progress of Moderna’s (MRNA) late-stage pipeline candidates on the fourth-quarter earnings call that reduce its dependence on Spikevax.
Business, Services And Guides For Music Labels
Business, Services And Guides For Music Labels
Investor focus is likely to be on the progress of Moderna’s (MRNA) late-stage pipeline candidates on the fourth-quarter earnings call that reduce its dependence on Spikevax.